vs
Side-by-side financial comparison of BayCom Corp (BCML) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $18.9M, roughly 1.4× Electromed, Inc.). BayCom Corp runs the higher net margin — 26.5% vs 14.6%, a 11.9% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $2.4M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs 2.9%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
BCML vs ELMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.9M | $18.9M |
| Net Profit | $6.9M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | 36.6% | 19.2% |
| Net Margin | 26.5% | 14.6% |
| Revenue YoY | 9.4% | 16.3% |
| Net Profit YoY | 12.1% | 40.3% |
| EPS (diluted) | $0.63 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | $18.9M | ||
| Q3 25 | $25.7M | $16.9M | ||
| Q2 25 | $24.7M | $17.4M | ||
| Q1 25 | $24.3M | $15.7M | ||
| Q4 24 | $23.7M | $16.3M | ||
| Q3 24 | $25.6M | $14.7M | ||
| Q2 24 | $23.8M | $14.8M | ||
| Q1 24 | $24.5M | $13.9M |
| Q4 25 | $6.9M | $2.8M | ||
| Q3 25 | $5.0M | $2.1M | ||
| Q2 25 | $6.4M | $2.2M | ||
| Q1 25 | $5.7M | $1.9M | ||
| Q4 24 | $6.1M | $2.0M | ||
| Q3 24 | $6.0M | $1.5M | ||
| Q2 24 | $5.6M | $1.8M | ||
| Q1 24 | $5.9M | $1.5M |
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | 36.6% | 19.2% | ||
| Q3 25 | 26.3% | 15.8% | ||
| Q2 25 | 35.3% | 17.5% | ||
| Q1 25 | 31.6% | 13.6% | ||
| Q4 24 | 34.2% | 15.6% | ||
| Q3 24 | 32.4% | 13.2% | ||
| Q2 24 | 31.9% | 15.7% | ||
| Q1 24 | 33.3% | 13.3% |
| Q4 25 | 26.5% | 14.6% | ||
| Q3 25 | 19.5% | 12.6% | ||
| Q2 25 | 25.8% | 12.7% | ||
| Q1 25 | 23.4% | 12.1% | ||
| Q4 24 | 25.9% | 12.1% | ||
| Q3 24 | 23.5% | 10.0% | ||
| Q2 24 | 23.6% | 12.3% | ||
| Q1 24 | 24.0% | 10.8% |
| Q4 25 | $0.63 | $0.32 | ||
| Q3 25 | $0.46 | $0.25 | ||
| Q2 25 | $0.58 | $0.26 | ||
| Q1 25 | $0.51 | $0.21 | ||
| Q4 24 | $0.55 | $0.22 | ||
| Q3 24 | $0.54 | $0.16 | ||
| Q2 24 | $0.50 | $0.20 | ||
| Q1 24 | $0.51 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.6M | $45.4M |
| Total Assets | $2.6B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $15.3M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | $338.6M | $45.4M | ||
| Q3 25 | $334.3M | $44.7M | ||
| Q2 25 | $330.6M | $43.2M | ||
| Q1 25 | $329.3M | $43.9M | ||
| Q4 24 | $324.4M | $43.6M | ||
| Q3 24 | $321.7M | $41.5M | ||
| Q2 24 | $315.3M | $44.5M | ||
| Q1 24 | $314.2M | $42.5M |
| Q4 25 | $2.6B | $54.9M | ||
| Q3 25 | $2.6B | $53.6M | ||
| Q2 25 | $2.6B | $53.8M | ||
| Q1 25 | $2.6B | $52.5M | ||
| Q4 24 | $2.7B | $52.3M | ||
| Q3 24 | $2.6B | $48.9M | ||
| Q2 24 | $2.6B | $52.2M | ||
| Q1 24 | $2.6B | $48.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $3.0M |
| Free Cash FlowOCF − Capex | $30.1M | $2.4M |
| FCF MarginFCF / Revenue | 116.2% | 12.7% |
| Capex IntensityCapex / Revenue | 6.7% | 3.4% |
| Cash ConversionOCF / Net Profit | 4.64× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | $3.0M | ||
| Q3 25 | $7.3M | $169.0K | ||
| Q2 25 | $6.4M | $3.9M | ||
| Q1 25 | $9.3M | $2.1M | ||
| Q4 24 | $30.4M | $3.2M | ||
| Q3 24 | $9.6M | $2.3M | ||
| Q2 24 | $7.7M | $4.5M | ||
| Q1 24 | $5.1M | $1.4M |
| Q4 25 | $30.1M | $2.4M | ||
| Q3 25 | $6.2M | $-83.0K | ||
| Q2 25 | $5.6M | $3.7M | ||
| Q1 25 | $9.1M | $1.9M | ||
| Q4 24 | $28.7M | $2.9M | ||
| Q3 24 | $9.4M | $2.3M | ||
| Q2 24 | $7.4M | $4.5M | ||
| Q1 24 | $3.9M | $1.3M |
| Q4 25 | 116.2% | 12.7% | ||
| Q3 25 | 24.3% | -0.5% | ||
| Q2 25 | 22.8% | 21.4% | ||
| Q1 25 | 37.6% | 12.2% | ||
| Q4 24 | 121.1% | 18.0% | ||
| Q3 24 | 36.6% | 15.5% | ||
| Q2 24 | 31.2% | 30.1% | ||
| Q1 24 | 16.1% | 9.1% |
| Q4 25 | 6.7% | 3.4% | ||
| Q3 25 | 4.3% | 1.5% | ||
| Q2 25 | 3.0% | 0.8% | ||
| Q1 25 | 0.6% | 1.0% | ||
| Q4 24 | 7.2% | 1.4% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 1.0% | 0.1% | ||
| Q1 24 | 4.7% | 0.6% |
| Q4 25 | 4.64× | 1.10× | ||
| Q3 25 | 1.47× | 0.08× | ||
| Q2 25 | 1.00× | 1.75× | ||
| Q1 25 | 1.63× | 1.10× | ||
| Q4 24 | 4.96× | 1.60× | ||
| Q3 24 | 1.60× | 1.57× | ||
| Q2 24 | 1.37× | 2.46× | ||
| Q1 24 | 0.86× | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCML
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
